Article
Integrated UPLC-MS/MS Metabolomics Reveals Novel Metabolic Markers for Type I Endometrial Carcinogenesis in Clinical Samples
2026-07-14
Abstract excerpt
<title>Abstract</title> <p> Objective This study aimed to identify differential metabolites between type I endometrial cancer (EC) and normal tissues (NT) using untargeted metabolomics based on ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). We further explored key metabolites and metabolic pathways to underpin clinical diagnosis and treatment. Methods Paired cancerous and normal...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8bc56961-75d5-5a3a-914a-1a7159e6124d
- DOI
- 10.21203/rs.3.rs-9963643/v1
